TRANSACTIVATION OF CD23 BY EBNA-2 AND LMP

EBNA-2 和 LMP 对 CD23 的反激活

基本信息

  • 批准号:
    3085880
  • 负责人:
  • 金额:
    $ 9.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-08-01 至 1993-07-31
  • 项目状态:
    已结题

项目摘要

Epstein-Barr virus (EBV) is a herpes virus which can cause nasopharyngeal carcinoma, African Burkitt's lymphoma, monoclonal and polyclonal lymphoproliferative disorders in immunocompromised host. EBV preferentially infects normal B lymphocytes and results in rapid and efficient transformation of B lymphocytes into immortalized cell lines. Six nuclear proteins: EBNA-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C, EBNA-LP, and one membrane protein LMP; are expressed in latently infected growth- transformed lymphocytes. By genetic analysis, EBNA-2 has been shown to be essential for EBV induced transformation. The exact mechanism by which EBNA-2 contributes to growth transformation is still unknown. EBNA-2 confers a phenotypic change in growth and may function by specifically inducing cellular CD23 gene expression. CD23 was detected on B cell surface within 24 hours after EBV infection. Immortalized B cells arise almost exclusively from CD23 positive cell population. LMP, the latent membrane protein, has direct transforming ability in rodent fibroblast, cooperatively induces CD23 in BJAB cells (EBV negative Burkitt's lymphoma cells). Detailed studies of the transactivation mechanism of cellular CD23 by EBNA-2 and LMP will enable us to understand how these latent genes contribute to B lymphocyte transformation as well as normal B cell growth regulation. Specifically, the goals of this proposal are to determine: (1) the mechanism by which EBNA-2 and LMP induce CD23, (2) the EBNA-2 domains essential for transformation and CD23 transactivation (3) the role of CD23 expression in EBV induced growth transformation, both by overexpression and inhibition of CD23
爱泼斯坦-巴尔病毒(EBV)是一种疱疹病毒,可引起鼻咽炎

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SO F TSANG其他文献

SO F TSANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SO F TSANG', 18)}}的其他基金

TRANSACTIVATION OF CD23 BY EBNA-2 AND LMP
EBNA-2 和 LMP 对 CD23 的反激活
  • 批准号:
    3085879
  • 财政年份:
    1990
  • 资助金额:
    $ 9.21万
  • 项目类别:

相似海外基金

Analysis of expression of Cd antigens in retinoblastoma, and its application for disease classification and therapeutic strategy
视网膜母细胞瘤中Cd抗原的表达分析及其在疾病分类和治疗策略中的应用
  • 批准号:
    25670726
  • 财政年份:
    2013
  • 资助金额:
    $ 9.21万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了